Cause of death, by non-communicable diseases, ages 5-14 in Serbia
Serbia: Cause of death, by non-communicable diseases, ages 5-14 was 71.2% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14 in Serbia, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total deaths ages 5-14.
Analysis
The most recent figure for cause of death, by non-communicable diseases, ages 5-14 in Serbia is 71.2%, measured in 2021. That is the highest value across all 6 years on record.
That represents a change of up 2.2% on the previous year and up 13.3% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14 in Serbia peaked at 71.2% in 2021 and was at its lowest, 49.3%, in 2000.
Serbia ranks 7th of 185 countries on this measure, in the top 10%.
Cause of death, by non-communicable diseases, ages 5-14 in Serbia, year by year
| Year | % of total deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 49.3% | — |
| 2010 | 62.9% | +27.6% |
| 2015 | 61.8% | -1.7% |
| 2019 | 61.5% | -0.5% |
| 2020 | 69.7% | +13.4% |
| 2021 | 71.2% | +2.2% |
Serbia compared with similar countries
- Serbia's 71.2% is above the median for upper middle income countries, which is 38.5%, 1.9× the median. (55 countries reporting)
- Serbia's 71.2% is above the median for Europe & Central Asia, which is 58.0%, 1.2× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 49.3% | 49.3% | 49.3% | 1 |
| 2010s | 62.1% | 61.5% | 62.9% | 3 |
| 2020s | 70.5% | 69.7% | 71.2% | 2 |
Countries ranked near Serbia
More health data for Serbia
- Un projection of annual infant deaths, annual growth rate -5.26 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3584 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,502 deaths per 1,000 people (2090)
- Number of infants who die before age 1 18 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.67 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.022 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.67 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14 in Serbia?
- Cause of death, by non-communicable diseases, ages 5-14 in Serbia was 71.2% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14 recorded in Serbia?
- The highest recorded value was 71.2% in 2021.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14 recorded in Serbia?
- The lowest recorded value was 49.3% in 2000.
- How does Serbia rank for cause of death, by non-communicable diseases, ages 5-14?
- Serbia ranks 7th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14 rising or falling in Serbia?
- Over the last ten years it is up 13.3%. The long-run trend across the full record is rising.
- Where does this Serbia data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.